Varonis Recognized by Gartner in Market Guide for User and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Varonis Recognized by Gartner in Market Guide for User and Entity Behavior Analytics

NEW YORK, Dec. 27, 2016 (GLOBE NEWSWIRE) -- Varonis Systems, Inc.  (NASDAQ: VRNS ), a leading provider of software solutions that protect data from insider threats and cyberattacks, has been named by Gartner as a “Representative Vendor” in its new Market Guide for User and Entity Behavior Analytics (UEBA) for the second consecutive year.

Varonis DatAlert protects and monitors data assets, from suspicious or anomalous activity to detecting critical events like ransomware, compromised files and cyberattacks. It automates threat detection with predictive threat models built on advanced analytics, user behavior and machine learning. Unlike other UBA and SIEM solutions, Varonis is not dependent on external data sources and captures high-fidelity auditing data directly from disparate monitored systems, to combine that information into DatAlert for a holistic view across an organization’s unstructured data.

Authored by Gartner analysts Avivah Litan, Tricia Phillips and Toby Bussa, the Market Guide recommends that security and risk management leaders focused on security monitoring and operations should “choose UEBA vendors aligned to the threats you want to detect, such as malicious insiders and external hackers, and those with solutions that align with your use cases. Fill gaps in existing security tools (for example, security event monitoring).”

David Gibson, Vice President of Strategy and Market Development at Varonis, said, “It’s incredible in today’s threat environment how many risk assessments reveal sizeable exposures through loose internal access controls. Valuable and sensitive data is frequently left open for anyone inside that organization to see and steal. Worse, very few organizations can see when insiders are accessing data abnormally.  Since our inception, Varonis has used user behavior analytics to make recommendations about where access can be safely reduced. Through DatAlert, we’ve made significant advances in using behavior analytics to learn the identities of executives, administrators and service accounts, profile how they use data, and spot unusual data access activity that might indicate a misbehaving employee or hijacked account. We are pleased to be included by Gartner in this important category and for our solution to be so closely aligned with Gartner’s recommendations. As we keep innovating for our existing customers and those we have yet to meet, we look forward to adding to our capabilities and continuing to stop malicious actors in their tracks.”

In assessing the market growth of UEBA technologies, the Gartner report states, “Gartner client interest in UEBA grew significantly over the past year, reflecting increasing awareness of the market, vendors and applicable use cases by buyers. Market consolidation was minimal over the last 12 months, with few mergers or acquisitions. Few vendors entered the UEBA market, but vendors that added or claimed to already have UEBA functionality in their solutions increased. Gartner continues to see growth in the market as stand-alone UEBA vendors reported increased interest that resulted in revenue growth. Gartner expects revenue for stand-alone UEBA products to surpass $200 million by the end of 2017.”

The Varonis Metadata Framework is the basis for a wide range of use cases including UEBA, sensitive data classification and remediation, identity and access rights management, enterprise search, and storage reduction. Thousands of organizations around the world rely on Varonis to curtail over-exposure of their most valuable and sensitive data and help prevent the inevitable network breaches for causing harm.

Additional Resources

Source: Gartner, Market Guide for User and Entity Behavior Analytics, December 8, 2016

Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Varonis Varonis is a leading provider of software solutions that protect data from insider threats and cyberattacks. Through an innovative software platform, Varonis allows organizations to analyze, secure, manage, and migrate their volumes of unstructured data. Varonis specializes in file and email systems that store valuable spreadsheets, word processing documents, presentations, audio and video files, emails, and text. This rapidly growing data often contains an enterprise's financial information, product plans, strategic initiatives, intellectual property, and confidential employee, customer or patient records. IT and business personnel deploy Varonis software for a variety of use cases, including data security, governance and compliance, user behavior analytics, archiving, search, and file synchronization and sharing. With offices and partners worldwide, Varonis had approximately 5,000 customers as of September 30, 2016, spanning leading firms in financial services, healthcare, public, industrial, insurance, energy and utilities, media and entertainment, consumer and retail, technology and education sectors.

News Media Contact: Jennifer LuPiba 614-338-9889 jlupiba@varonis.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 29

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 28

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 24

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 35

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 30

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 20

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

ZTO Express Highlights Convertible Note Repurchase Opportunity

Updated Category News Views 114

Understanding ZTO Express's Convertible Note Repurchase Right ZTO Express (Cayman) Inc. (NYSE: ZTO), a key player in the express delivery sector, recently informed its bondholders about their rights regarding the 1.50% Convertible Senior Notes due 2027. The company offers an opportunity for holders to request the repurchase of their notes in cash, giving them a strategic...

Continue Reading
EVERSANA's AI Expands: Revolutionizing Life Sciences

Updated Category News Views 11

A Bold Leap in AI Commercialization Look, fresh off the press, EVERSANA is making some waves. They’ve expanded their AI-powered commercialization platform, aiming to overhaul life sciences operations. Sounds like a mouthful, right? Well, let's break it down. This expansion isn't just a facelift; it's part of a bigger vision to create a nimble, AI-native ecosystem for...

Continue Reading
Wabtec Corporation's Q3 Performance: Growth and Opportunities

Updated Category News Views 93

Wabtec Corporation Delivers Strong Third Quarter Results Wabtec Corporation (NYSE: WAB) has announced a solid performance for the third quarter, reporting a notable 4.5% increase in sales, reaching $2.7 billion compared to the same period last year. This growth can be attributed to the robust performance in its freight and transit sectors. The company also shared that the...

Continue Reading
Exploring Job Creation and Economic Growth by Argosy Investments

Updated Category News Views 119

Argosy Real Estate Partners and Economic Development Argosy Real Estate Partners, a dedicated private real estate investment manager, has recently shared compelling insights from its Opportunity Zone Economic Impact Analysis. The firm emphasizes its commitment to fostering positive growth in communities by investing in Qualified Opportunity Zones. This analysis showcases...

Continue Reading
Join Vow ASA for the Exciting Q3 2024 Results Presentation

Updated Category News Views 101

Vow ASA Invites You to Its Third Quarter 2024 Presentation Vow ASA (OSE: VOW) is gearing up to unveil its much-anticipated report for the third quarter of 2024. Mark your calendars for this significant event on a Tuesday morning, when the company's financial performance and insights will be shared with the world. Presentation Details The results will be available for...

Continue Reading